Medicine and Dentistry
Inpatient
100%
Pancreas Cancer
77%
Patient
73%
Analysis
49%
Anal Sphincterotomy
46%
Chemotherapy
41%
Bile Duct Stone
36%
Endoscopic Retrograde Cholangiopancreatography
35%
Balloon Dilatation
34%
Stent
30%
Phase II Trials
30%
Retrospective Study
30%
Pancreas Enzyme
30%
Metal
30%
Enzyme Replacement Therapy
30%
Biliary Tract Cancer
30%
Diagnosis
30%
Pancrelipase
28%
Self-Expandable Metallic Stent
24%
Pancreas Adenocarcinoma
23%
Meta-Analysis
23%
Folinic Acid
22%
Hazard Ratio
21%
Endoscopic Sphincterotomy
20%
Development
19%
Phase I Trials
18%
Association
18%
Biliary Tract Drainage
17%
Common Bile Duct Stone
17%
Recurrent Disease
17%
Cannulation
17%
Second-Line Chemotherapy
17%
Overall Survival
16%
Clinical Anatomy
15%
Pancreas Disease
15%
Neoadjuvant Chemotherapy
15%
Malignant Ascites
15%
Protein Intake
15%
Cholangitis
15%
Diabetes Mellitus
15%
Suction
15%
Paclitaxel
15%
Interventional Ultrasonography
15%
Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
15%
Single Balloon Enteroscopy
15%
Gastrectomy
15%
Gemcitabine
15%
Stricture
15%
Cystic Pancreatic Lesion
15%
Antithrombotic
15%
Pharmacology, Toxicology and Pharmaceutical Science
Biliary Tract Cancer
77%
Gemcitabine
61%
Pancreas Cancer
46%
Paclitaxel
30%
Survival
30%
Pancreas Enzyme
30%
Replacement Therapy
30%
Pancrelipase
28%
Folinic Acid
22%
Overall Survival
19%
Combination Therapy
16%
Acalculous Cholecystitis
15%
Lenvatinib
15%
Retrospective Study
15%
Cholestasis
15%
Pylorus Stenosis
15%
Angiotensin
15%
Renin
15%
CA 19-9 Antigen
15%
Cisplatin
15%
Peritoneum Metastasis
15%
Thromboembolism
15%
4-Aminobenzoic Acid
11%
Progression Free Survival
9%
Diseases
9%
Neoplasm
8%
Exocrine Pancreatic Insufficiency
8%
Chemotherapy
6%
First-Line Chemotherapy
6%
Cachexia
6%
Toxicity
5%
Pancreatic Lipase
5%
Stomatitis
5%
Malnutrition
5%
Anorexia
5%